References
- Sentinel lymph node status is a main prognostic parameter needful for the correct staging of patients with melanoma thicker than 4 mm: single institutional experience and literature meta-analysis. J Invest Surg, in press.
- Balch CM, Gershenwald JE, Soong SJ, et al. Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol. 2009;27:6199–6206. doi:10.1200/JCO.2009.23.4799. PMID: 19917835
- Cook MG, Massi D, Blokx WAM, et al. New insights into naevoid melanomas: A clinicopathological reassessment. Histopathology. 2017; 7:943–950. doi:10.1111/his.13317. PMID: 28741688
- Morton DL, Thompson JF, Cochran AJ, et al. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med. 2014;370:599–609. doi:10.1056/NEJMoa1310460. PMID: 24521106
- White I, Fortino J, Curti B, Vetto J. Clinical impact of sentinel lymph node biopsy in patients with thick (>4 mm) melanomas. Am J Surg. 2014;207:702–707 doi:10.1016/j.amjsurg.2013.12.022. PMID: 24791630
- Faries MB, Thompson JF, Cochran AJ, et al. Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma. N Engl J Med. 2017;376:2211–2222 doi:10.1056/NEJMoa1613210. PMID: 28591523
- Coit DG, Thompson JA, Algazi A, et al. Melanoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2016;14:450–473. doi:10.6004/jnccn.2016.0051. PMID: 27059193
- Balch CM, Soong SJ, Gershenwald JE, et al. Prognostic factors analysis of 17,600 melanoma patients: Validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol. 2001;19:3622–3634. doi:10.1200/JCO.2001.19.16.3622. PMID: 11504744
- Wasif N, Etzioni D, Haddad D, et al. Staging studies for cutaneous melanoma in the United States: A population-based analysis. Ann Surg Oncol. 2015;22:1366–1370 doi:10.1245/s10434-014-4268-3. PMID: 25472650
- Gerami P, Cook RW, Wilkinson J, et al. Development of a prognostic genetic signature to predict the metastatic risk associated with cutaneous melanoma. Clin Cancer Res. 2015; 21:175–183. doi:10.1158/1078-0432.CCR-13-3316. PMID: 25564571
- Berger AC, Davidson RS, Poitras JK, et al. Clinical impact of a 31-gene expression profile test for cutaneous melanoma in 156 prospectively and consecutively tested patients. Curr Med Res Opin. 2016;32:1599–1604. doi:10.1080/03007995.2016.1192997. PMID: 27210115